Apimeds’ Subsidiary MindWave Innovations Enters Into Shareholders’ And JV Agreement With Skalup Capital To Establish Insurance And Technology Business In Bermuda Under Working Brand Monaco Insurance
Benzinga Newsdesk 1 hour ago
News
Joint venture pairs MindWave’s blockchain infrastructure and digital-asset-backed capital, in the form of staking, with Skalup’s insurance expertise to build reinsurance capacity in one of the world’s leading insurance
Joint venture pairs MindWave’s blockchain infrastructure and digital-asset-backed capital, in the form of staking, with Skalup’s insurance expertise to build reinsurance capacity in one of the world’s leading insurance markets
MATAWAN, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- via IBN — MindWave Innovations Inc. USA ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has entered into a Shareholders’ and Joint Venture Agreement with Singapore-based Skalup Capital Pte Ltd ("Skalup") to establish an insurance and technology business in Bermuda under the working brand Monaco Insurance, subject to final regulatory approval.
The agreement brings together MindWave’s blockchain technology and digital infrastructure with Skalup’s underwriting expertise and regulatory support. The proposed venture will pursue the necessary insurance licensing from the Bermuda Monetary Authority ("BMA"). Insurance operations and product launches will be subject to incorporation and applicable regulatory approvals.
